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Abstract
Neonates are exposed to Staphylococcus aureus shortly after birth and can become 
colonized quickly after contact with adult skin or the environment. Methicillin-resistant S. 
aureus (MRSA) constitutes part of the growing global health problem associated with an 
increasing number of infections and often multidrug resistant in nature which now poses 
serious therapeutic problems to clinicians. Eighty-three (83) samples were collected 
which were cultured on appropriate bacteriological media. Bacterial isolates (S. aureus) 
were identified by standard biochemical tests and confirmed using PCR targeting the 16S 
rRNA. The MRSA was determined using Oxacillin antibiotic disk and confirmed by the 
presence of MecA gene. Antibiotic susceptibility of the MRSA isolates to eleven antibiotics 
was performed according to Clinical Laboratory Standard testing Institute (CLSI) 
guidelines.  Out of the 83 individuals tested, 25 yielded S. aureus of which 22 (88.0%) of 
them were MRSA positive, 10 (45.5%) females and 12 (54.5%) males. The antibiotic 
resistant pattern of the 22 MRSA isolates showed Quinupristin/Dalfopristin 13 (59.1%), 
Fusidic acid 6 (27.3%), Linezolid 8 (36.4%), Clindamycin 10 (45.5%), Vancomycin 
5(22.7%), Cefepime 3(13.6%), Doxycycline 4(18.2%), Sulphamethoxazole 22(100%), 
Fosfomycin 7(31.8%), Cephalexin 7(31.8%), Trimethoprim 19(86.4%). The MIC 
determination for vancomycin from MRSA isolates showed antibiotic concentration of 
4.9 µg/ml and 8.7 µg/ml.  This work showed that there is high prevalence rate of 
resistance to many classes of antibiotic warranting continued surveillance and 
antimicrobial stewardship. Therefore effective antibiotic susceptibility test should be 
conducted before prescribing an antibiotic to patients, in as much as patients should 
strictly adhere to antibiotic prescription to mitigate abuse of drugs. 
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Introduction
Staphylococcus aureus is one of the major 
human pathogens, significantly contributing to 
Hospital and community acquired infection (Ugwu 
et al., 2016). The emergence of Methicillin-
Resistant Staphylococcus aureus (MRSA) that is 
cross resistant to most beta-lactams reduces the 
treatment options for staphylococcal infections 
(Saravanan et al., 2013).
Methicillin-resistant Staphylococcus 
aureus (MRSA) strains have been reported by 
many investigators to have developed resistance 
to antibiotics through enzymatic degradation, 
alteration of bacteria proteins, efflux of antibiotics 
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and the risk factors include childcare/crowded 
living conditions and indiscriminate use of 
antibiotics (Samore et al., 2001; Tenover, 2006). 
Presence of resistance plasmids (R-plasmids) in 
cells makes the cells resist the effect of antibiotics 
and makes chemotherapy of infections very 
difficult. Plasmids are extrachromosomal genetic 
elements that are transferred from one cell to 
another through horizontal gene transfer (Sheikh 
et al., 2003).
 In neonates and children, the prolonged 
hospitalization, and antibiotic exposure, has 
been indicated to increase risk of infection with 
multi-resistant pathogens, the greater the 
duration of exposure, the greater the risk of the 
development of resistance irrespective of the 
severity of the need for antibiotics (Shane and 
Stoll, 2014).
 MRSA infections has been reported to be 
responsible for more deaths in the US each year 
than AIDS according to Kavanagh et al. (2017). 
MRSA-related deaths was also of major concern 
to England and Wales (Klevens et al., 2007) as 
MRSA is seen to have increased the rate of 
mortality in UK since 1993 (Blot et al., 2002). 
Most African countries including Nigeria 
(29.6%), Kenya (27.7%), Cameroon (21.3%), 
Cote D'Ivoire (16.8%), and Morocco (14.4%) 
(Kesah, 2003) have recorded higher isolation 
rate of MRSA. However, there are great chances 
of MRSA to be transmitted outside hospital for 
the fact that there is no checkup for MRSA 
decolonization when patients are discharged 
from hospitals and this raises serious concerns 
about the possibility of transmission of MRSA 
outside the health care system. The possibility of 
MRSA becoming the common form of S. aureus in 
a community will make treatment much more 
difficult (Akujobi et al., 2013). 
 As resistance towards antibiotic becomes 
more common, a greater need for alternative 
treatments arises. However, despite a push for 
new antibiotic therapies, there has been a 
continued decline in the number of newly 
approved drugs. Antibiotic resistance therefore 
poses a significant problem (Emeka-Nwabunnia 
et al., 2015). Development of new antimicrobials 
presently is difficult, coupled with increasingly 
common and novel-resistance mechanisms by 
organisms which provide challenges for 
clinicians. For this reason, though clinicians and 
scientists, anticipate for the development of new 
antimicrobial agents, are looking forward to 
investigate possibilities of using previously 
discarded agents or improve established agents 
in a different way to ameliorate the situation 
(Benjamin, 2014). In one of such ways like 
testing for the different concentrations of such 
antibiotics that organism have developed 
resistance for and determining the new minimum 
inhibitory concentration (MIC) for which the 
resistant strain of the organism will be 
susceptible to. 
 This necessitates the need for many 
epidemiological investigations which have been 
focused on S. aureus strains isolated from 
patient's specimens or invasive infections, but 
only a few have studied the prevalence of MRSA 
collected from pediatric units in Anambra state.
Methodology
Study Area and Population
 The study was carried out in Anambra 
State located in the South Eastern part of Nigeria. 
The area was selected because of some 
suspected risk factors for MRSA infection and 
colonization such like over crowdedness, poor 
sanitation and hygiene and also due to the 
familiarity of the area by the researcher.  The 
study was conducted on 83 children under the 
age of five (0 month to 59 months) presenting at 
the Children Out-patient clinic (CHOP), paediatric 
wards and children emergency ward of the two 
selected hospitals; De Vince Memorial Children 
Specialist Hospital Ugwuagba, Obosi and General 
Hospital Onitsha in Anambra State.   
Ethical Considerations
 Written ethical approval was obtained 
from the State Hospital Management Board 
(SHMB) (Ref No. SHMB/AD/488/Vol II/44) under 
the jurisdiction of the Ministry of Health Anambra 
State (Ref No. MH/AD/12/T/III/313). Signed 
informed consent was also obtained from 
participant's care-givers included in the study. 
Identification of bacterial Isolates
 Samples were collected from nostrils, ear, 
skin and wound from children using sterile swab 
sticks while sterile needles was used to collect 
blood samples. The swabs were immediately 
inoculated on Baird-Parker media (Titan Biotech 
LTD, India. Lot no. M3F8HP01) and incubated for 
24 h. All Gram-positive cocci isolates that were in 
c l u s t e r s  w e r e  s u b j e c t e d  t o  
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standard biochemical characterization tests; 
coagulase and catalase test for Staphylococcus 
aureus (Cheesbrough, 2006). The isolates were 
confirmed by molecular method. The 
chromosomal DNA was extracted by boiling 
according to the method of Zhang et al. (2004), 
by sub culturing in 5 mL of Mueller Hinton broth 
and incubated at 37 ºC overnight preceding DNA 
harvesting. Molecular identity of the cultures was 
tested based on PCR targeting the 16S rRNA 
according to McClure et al. (2006). Crude 
bacterial lysates of all cultures were prepared 
targeting a 756-bp internal fragment of the gene 
with primer concentrations of  100 µM as follows; 
forward: 5'- AAC TCT GTT ATT AGG GAA GAA CA -
3', and reverse 5'- CCA CCT TCC TCC GGT TTG  
TCA CC -3' (Inqaba Biotechnical company Pty, 
South Africa). PCR reaction mixture was 
optimized by adding to each 25 µL eppendorf  
tubes, 16.4 µL of sterile distilled deionised water, 
5 µL of PCR buffer, 1.5 µL of 1x MgCl , 0.5 µl of 2 
dNTP, 0.25 µL each of the forward and reverse  
primers and 0.1 µL of Taq DNA polymerase 
(Promega, USA). To completely make it a 25 µL 
reaction mixture, 1µL of DNA from the processed 
clinical isolates was added. PCR was carried out 
in a thermal cycler (Eppendoff Vapoprotect, 
Germany) with the reaction cycles consisting of 
an initial denaturation  of 94 ºC for 5 min; 34 
cycles of 55 ºC for 30 seconds, 52 ºC for 1min 
and 72 ºC for 1 min. A final extension step at 72 
ºC was continued for another 10 min. The PCR 
products were resolved on 2% agarose gels 
containing 0.5 μg/mL ethidium bromide and 
visualised on UV transilluminator using a photo 
documentation system (Clinix Science, China).
Phenotypic detection of MRSA using the Oxacillin 
d isc  (Oxoid ,  England)  and Molecular  
identification:
 Oxacillin screening test was conducted 
on all the confirmed S. aureus isolates by the 
agar screening method. The S. aureus isolates 
were standardized to 0.5 M McFarland standards 
and were inoculated aseptically onto the Muller-
Hinton agar plates. The plates were incubated 
0for exactly 24 hours at 37 C. Isolates positive to 
oxacillin disc were confirmed by the detection of 
the presence of Mec A gene. Polymerase chain 
reaction (PCR) assay according to the modified 
method of McClure et al. (2006), was used. 
Amplification of a single-target PCR bands 
corresponding to molecular size of 310bp for 
mecA gene with primers of MecA1 (5′ - GTA GAA 
ATG ACT GAA CGT CCG ATA A - 3′) and MecA2 
(5′- CCA ATT CCA CAT TGT TTC GGT CTA A - 3′) 
that were easily recognizable in agarose gel 
stained with ethidium bromide was determined.  
The condition was optimized by assaying the two 
primers concentrations and other PCR 
components as follows: 2 µl of template DNA 
preparations was added to a 25 µl final reaction 
volume containing, 10.25 µl of distilled deionised 
water, 12.5 µl of master mix, 0.25 µl of MecA 
forward and backward primers, with 
thermocycling conditions set at denaturation at 
94ºC for 5 mins, followed by 30 cycles of 
denaturation at 94ºC for 45 secs, annealing at 
55ºC for 45 secs and extension at 72ºC for 75 
secs and a final extension step at 72ºC for 10 
mins. The PCR products were also resolved on 
2% agarose gels containing 0.5 µg/mL ethidium 
bromide and documented using a gel 
documentation system (Clinix Science, China).
Antibiotic susceptibility testing (AST)
 The antibiotic resistance pattern of the 
isolates was determined against eleven 
antibiotics using Kirby – Bauer disc – diffusion 
method following the CLSI (2014) guidelines. 
The inoculation of the confirmed Oxacillin-
resistance S. aureus (MRSA) isolates was evenly 
distributed over the surface of the Muller-Hinton 
agar media in the petri dishes by rotating while 
streaking. The plates were allowed to set and the 
antibiotic sensitivity disc (Oxoid, England); 
Linezolid, Fusidic acid, Quinupristin/ Dalfopristin, 
Cephalexin, Cl indamycin, Vancomycin 
Fosfomycin, Trimethoprim, Sulphamethoxazole, 
Cefepime and Doxycycline were aseptically 
placed on their surfaces using a sterile forcep. 
0The plates were incubated at 37 C for 24 h and 
the resultant Inhibition Zone Diameters (IZDs) 
measured and recorded. These were then 
interpreted as susceptible and resistant 
according to standard specifications of CLSI.
Minimum Inhibitory concentration of Vancomycin 
Resistance Staphylococcus aureus 
 Two methicillin-resistant S. aureus 
isolates which showed resistance to vancomycin 
antibiotics disc (30µg/mg) were further 
subjected to Minimum Inhibitory Concentration 
test. Varied concentration of the antibiotic was 
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prepared above the CLSI recommended 
Minimum inhibitory Concentration standard for 
Vancomycin which is 30µg/mg (CLSI, 2008). The 
MIC of the Vancomycin antibiotic was conducted 
using broth dilution method on the two isolated 
VRSA over the concentration ranges  as follows; 
3.0µg/ml, 3.3µg/ml, 3.7µg/ml, 4.9µg/ml and 
8.7µg/ml. The vancomycin resistance was 
further confirmed using commercially prepared 
©Brain Heart Infusion (BHI) agar plates (Remel , 
USA) containing 6 µg/ml of vancomycin by 
inoculating 10 µl of 0.5 McFarland standard 
bacterial suspension on the plates.
 
Data collection for epidemiologic risk factors
  Epidemiologic risk factors related to 
demographic and medical history of the study 
population (Age, sex, previous antibiotic history, 
and previous hospital exposure of self or family 
member, current symptoms and family size) were 
gathered using unstructured questionnaires. It 
was unstructured because it requires free 
responses in the respondents' words and style. It 
was designed to permit free responses from 
participants rather than limited to specific 
alternatives. 
Statistical analysis
 The data were analyzed using the One-
sample t-test in SPSS version 20. Questionnaire 
data were recorded on the questionnaire forms 
and entered into a Microsoft Excel spreadsheet. 
Laboratory results were entered into the 
spreadsheet along with the corresponding 
participant's information as they become 
available. Descriptive statistics (including means, 
standard deviations, frequencies and 
percentage) were calculated for the socio-
demographic variables. All tests were 2-tailed, 
and a p<0.05 was considered statistically 
significant.
Results 
 A total of 83 individuals participated in 
the survey of which 41 (49.4%) were males and 
42 (50.6%) were females. The two sites of study 
and sample collected from each site were 
reported as 40 blood samples, 38 nose swabs, 3 
wound swabs, 1 ear swab and skin swab Out of 
the 83 samples, 25 were found to be 
Staphylococcus aureus. All the 25 isolates 
amplified the expected 756 bp of the 16rRNA 
gene confirming the identity of the S. aureus 
(figure 2). Table 1 shows the clinical 
characteristics of patients with MRSA isolates.
Antibiotic susceptibility test result
 Out of the 25 S. aureus isolates, 22 
(88.0%) showed resistance to Oxacillin (Oxoid, 
England) indicating Methicillin-resistant S. 
aureus. The 22 isolates amplified the expected 
310 bp of the Mec A gene confirming methicillin 
resistance (Figure 3). The antibiotic susceptibility 
profile showed that the 22 MRSA isolates were 
resistant to antibiotics tested in the following 
percentage, Cefepime (12%), Doxycycline 
(16%), Vancomycin (20%), Cephalexin (31.8%), 
Fosfomycin (18.2%), Fusidic acid (27.3), 
Linezolid (36.4%), Clindamycin (45.5%), 
Quinuprist in/Dalfoprist in (59.1%) and 
Trimethoprim (86.4%). MRSA isolates recorded 
complete resistance to Sulphamethoxazole 
(100%), as depicted by figure 1 below. 
Table 1: Clinical characteristics of patients with MRSA isolates
*** Exposure to hospital environment
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Figure 1: showing the susceptibility and resistance of the 22 MRSA isolates to different antibiotics
Figure 2: Showing the amplification of the targeted 16S rRNA confirming the organism to be S. 
aureus. Lane M represents the marker used, lane 1 and 2 represents negative and positive control 
respectively. Lane 3 - 26 represents the isolates.
Figure 3: Showing the amplification of the targeted Mec A gene confirming the presence of 
methicillin-resistant gene. Lane M represents the marker used, lane 1 and 2 represents positive and 
negative control respectively. Lane 3 - 24 represents the isolates.
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Discussions
 From the results stated above patient 
colonization or infection with a resistant strains 
of MRSA is not random. Methicillin-resistant S. 
aureus (MRSA) were isolated from Patients were 
characterized by a greater risk of infection due to 
previous exposure to antimicrobial therapy and 
have recorded previous hospital exposure or had 
a close contact with someone who have been to 
such exposures, which have been reported by 
many research works such like previous work by 
Alrabiah et al., (2016) and Kejela and Bacha, 
(2013).
 Out of 83 samples obtained, 25 samples 
showed positive S. aureus and of which 22 out of 
them were confirmed Methicillin-resistant, in this 
17 out of the 22 MRSA isolates were obtained 
from nasal swab which showed high prevalence 
rate of nasal colonization among children. This is 
line with the report by Ugwu et al., (2016) who 
stated that nasal carriage of S. aureus represents 
an effective and progressively prevalent risk 
factor for subsequent S. aureus infection.
 Among the 22 MRSA isolates from 
children included in the study, the statistically 
significant risk factors were obtained in children 
below the age of one year compared to other age 
range, children with previous antibiotic 
exposures and children whose family size is more 
than five. It was observed that patients under 
one year of age had the highest rate of 
colonization or infection with MRSA (12, 54.5%). 
This concurred with the previous research work 
by Alrabiah et al., (2016) and with the finding of 
study conducted by Gutierrez in California, USA, 
indicating that from 1985 to 2009, those less 
than one year of age had a higher colonization 
(Guteirrez et al., 2013). This further strengthens 
the evidence that young age is a risk factor for 
MRSA colonization and infection.
 In this study, there is a significant 
association between children from whom MRSA 
were isolated that had previous hospital 
exposure and that of those that do not have 
previous hospital exposure (p<0.05), also with 
children with previous antibiotic history and 
those that do not have any previous antibiotic 
history (p<0.05). Since there was no significant 
difference between children with hospital 
exposures and those that do not have hospital 
exposure, or those that have contact with family 
member who have both hospital exposures and 
those that don't, then this can indicate the 
dissemination of the hospital acquired 
methicillin-resistant S. aureus (HA-MRSA) from 
hospital to the community (outside hospital) and 
such contributes to high prevalence of MRSA 
outside the hospital as reported by Kejela and 
Bacha (2013). This can be possible since there is 
no decolonization process done on patients 
before being discharge from the hospital and this 
increases the tendencies of distributing hospital 
acquired strain in the community. The possibility 
that these children must have acquired this 
MRSA outside the hospital is very high. Family 
member exposure had no significant association 
with the children having MRSA because most of 
the children especially those under one year of 
age are still tender and are mostly under the care 
of their mothers.  Many reports have stated that 
over-crowdedness (McMichael, 2000; O'Malley 
et al., 2014), poor sanitation (Okeke, 2003) and 
antibiotic misuse associated with poverty (Chuc 
and Tomson, 1999; Kalu et al., 2008) can 
contribute to MRSA acquiring rate and all this are 
very common to the area of this study and this 
might have contributed to high prevalence of 
MRSA in this community. Furthermore, Nnachi et 
al., (2012) reported the high prevalence of MRSA 
among raw meat handlers in Onitsha, from this 
report cross-contamination can occur on the 
meat display table, even to the buyers and vice 
versa. This is of public health importance as it 
may play a potential role in transmitting the 
organism between animal and humans as well as 
the community. There was no observed 
significant difference in colonization rate 
between the male and female group. This 
observation is in line with the findings of Ajoke et 
al., (2012) in Jos, North Central Nigeria and 
Okwu et al., (2012) in Okada, Nigeria. They 
reported that sex is not a remarkable 
determinant in S. aureus colonization.
 The antibiotic resistant profile showed 
that the 22 MRSA isolate showed high resistant 
to most of the antibiotics tested in this study as 
shown in the figures above. The resistance 
observed in most of the reserved antibiotics such 
as Linezolid, which is in the WHO list of essential 
medicine and most important in basic health 
system (WHO, 2014) is gradually increasing and 
this gradual increase in resistance to this 
antibiotic is a threat to the global health as the 
pipeline of antibiotic is becoming dry. Most of 
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the antibiotics are not usually found over the 
counter in the community pharmacy shop but 
since the MRSA isolates in this study showed 
resistance in virtually all the antibiotics tested 
this can be as a result of the injudicious use of 
broad spectrum antibiotics which this organism 
must have developed resistance to, this will 
constitute the mechanism of which they resist 
this set of antibiotics which are not easily found 
in community. 
 The Minimum Inhibitory Concentration 
(MIC) conducted on the methicillin-resistant 
vancomycin-resistant S. aureus inhibiting the 
growth of the organism which is above the CLSI 
recommended Standard showed that there is 
need to increase the concentration are required 
to treat MRSA which are resistant to vancomycin 
which is the drug of choice. This resistance is 
greater than that observed by Emeka-
Nwabunnia et al. (2015) among S. aureus 
isolated from HIV patients. Believing that any 
time antibiotics are used, this puts biological 
pressure on bacteria that promotes the 
development of resistance (Hastings et al., 
2004). Antibiotics should be used when 
necessary and needed to prevent or treat 
disease. Research has shown that most of the 
time, antibiotics are prescribed when they are 
not needed or they are misused by prescribing 
wrong dose to a patient. This not only fails to 
help patients; it might cause harm. Like every 
other drug, antibiotics have side effects and can 
also interact or interfere with the effects of other 
medicines. This inappropriate utilization of 
antibiotics unnecessarily advance antibiotic 
resistance (Kalu et al., 2008).
 Antibiotics are a limited resource. The 
more that antibiotics are used today, the less 
likely they will still be effective in the future. 
Therefore, doctors and other health 
professionals around the world should be 
adopting the principles of responsible antibiotic 
use, often called antibiotic stewardship. 
Stewardship is a commitment to always use 
antibiotics only when they are necessary to treat, 
and in some cases prevent, disease; to choose 
the right antibiotics, and to administer them in 
the right way in every case. Effective stewardship 
ensures that every patient gets the maximum 
benefit from the antibiotics, avoids unnecessary 
harm from allergic reactions and side effects, and 
helps preserve the life-saving potential of these 
drugs for the future. Efforts to improve the 
responsible use of antibiotics have not only 
demonstrated these benefits but have also been 
shown to improve outcomes and save healthcare 
facilities money in pharmacy costs.
Conclusion
 It has been confirmed that MRSA has 
become a major cause of illness and death in the 
society. This research has established that MRSA 
exists around us and children are most 
vulnerable. Educating the people on the risk 
factors associated with MRSA transmission and 
ways of combating its spread, avoiding drug 
abuse and self-medication should be encouraged 
as this will play a vital role in mitigating the 
increase in prevalence rate of infection and 
colonization. 
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